For informational and research purposes only.
Research, explained. Explore peptides, supplements, hormone health, longevity and red light therapy with clear, practical breakdowns of what the studies actually tell us.
Find a topic you’re curious about and take a closer look.
Two trials tested different testosterone strategies and glucose outcomes. Compare their populations, results and safety findings before treating TRT as diabetes prevention.
Read articleTiming, meals, binding proteins and repeat testing help distinguish a single low result from a persistent testosterone deficiency.
Read articleTestosterone gel can leave transferable residue after drying. Learn what contact studies show and how product-specific precautions fit household life.
Read articleRecurrent urinary symptoms around menopause need both infection assessment and attention to local tissue changes. Here is what prevention trials show.
Read articleMicronized progesterone has evidence for specific uses. Molecular identity alone does not establish endometrial protection, better sleep or overall safety.
Read articleLean mass, skeletal muscle and strength are different measurements. Read the semaglutide and tirzepatide studies without turning scan results into muscle diagnoses.
Read articleAfamelanotide can change pigmentation and short-term UV responses. Those findings do not establish that tanning peptides prevent skin cancer.
Read articleA better workout can coexist with worse sleep. Caffeine timing trials show why dose, the whole day's intake and next-day experience belong in the same review.
Read articleHow repeated zinc products can lower copper absorption, why neurological symptoms matter, and what to review before adding another mineral.
Read articleALA trials show some short-term diabetic-neuropathy symptom benefits, but route, long-term outcomes, combination therapy and safety change the interpretation.
Read articleSmall meal studies, uncertain longer-term glucose effects and a retracted weight-loss trial make the vinegar story more limited than the headlines.
Read articleWhy REDEFINE 1 reports 20.4% and 22.7% weight reduction, what each analysis includes, and how dose flexibility changes the interpretation.
Read article134–145 of 600 articles
